Profil
Elaine Chiquette served as the Chief Scientific Officer at Gelesis, Inc. from 2017 to 2022, and at Gelesis Holdings, Inc. from 2022 to 2023.
Prior to her work at Gelesis, she earned an undergraduate degree from Université Laval and a doctorate from the University of Texas Health Science Center At San Antonio.
Anciens postes connus de Elaine Chiquette
| Sociétés | Poste | Fin |
|---|---|---|
| GELESIS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 30/10/2023 |
| GELESIS INC | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Formation de Elaine Chiquette
| Université Laval | Undergraduate Degree |
| University of Texas Health Science Center At San Antonio | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GELESIS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |
